[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Studying Multiple Versions of a Cellular or Gene Therapy Pr...[ Price : $8.95]
Federal Register notice: FDA posts a final guidance entitled M10 Bioanalytical Method Validation and Study Sample Analysis.[ Price : $8.95]
A Phase 3 trial of GSKs accelerated-approved Blenrep (belantamab mafodotin) in patients with relapsed or refractory multiple myelo...[ Price : $8.95]
FDA slaps a clinical hold on a Verve Therapeutics IND for its VERVE-101 in patients with heterozygous familial hypercholesterolemi...[ Price : $8.95]
Verrica Pharmaceuticals says it is filing an NDA resubmission in the first quarter next year for VP-102 to treat molluscum contagi...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled Postmarket Surveillance of Medical Devices ...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension entitled Certification of Identity; Form FDA 39...